APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medication for Dental

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medication for Dental Market Outlook and Growth Opportunities 2026

30 December 2025209 pages

Choose your research edition.

Industry ResearchMedication for Dental Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Medication for Dental Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medication for Dental Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medication for Dental Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Medication for Dental Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Medication for Dental market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medication for Dental is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medication for Dental is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medication for Dental is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medication for Dental market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medication for Dental market include Teva, Sun Pharmaceutical, Johnson & Johnson, Qilu Pharmaceutical, Novartis, Mylan, GSK, Bayer and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medication for Dental market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medication for Dental and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medication for Dental revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medication for Dental market.

Medication for Dental Segment by Company

Teva

Sun Pharmaceutical

Johnson & Johnson

Qilu Pharmaceutical

Novartis

Mylan

GSK

Bayer

Lupin

Lingrui

Galderma

Dr. Reddy's

CR SANJIU

Cipla

Bausch Health

Aurobindo

Almirall

Medication for Dental Segment by Type

NSAID

OTC Analgesic Medications

Opioid

Medication for Dental Segment by Application

Drug Store

Hospital

Other

Medication for Dental Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Medication for Dental status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medication for Dental key companies, revenue, market share, and recent developments.

3. To split the Medication for Dental breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medication for Dental market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medication for Dental significant trends, drivers, influence factors in global and regions.

6. To analyze Medication for Dental competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medication for Dental market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medication for Dental and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medication for Dental.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medication for Dental industry.

Chapter 3: Detailed analysis of Medication for Dental company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medication for Dental in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medication for Dental in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medication for Dental Industry Trends Table 2. Medication for Dental Industry Drivers Table 3. Medication for Dental Industry Opportunities and Challenges Table 4. Medication for Dental Industry Restraints Table 5. Global Medication for Dental Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medication for Dental Revenue Share by Company (2021-2026) Table 7. Global Medication for Dental Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medication for Dental Key Company Manufacturing Base & Headquarters Table 9. Global Medication for Dental Company, Product Type & Application Table 10. Global Medication for Dental Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medication for Dental by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of NSAID Table 15. Significant Companies of OTC Analgesic Medications Table 16. Significant Companies of Opioid Table 17. Global Medication for Dental Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Medication for Dental Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Medication for Dental Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Medication for Dental Sales Value Share by Type (2021-2026) Table 21. Global Medication for Dental Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Drug Store Table 23. Significant Companies of Hospital Table 24. Significant Companies of Other Table 25. Global Medication for Dental Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medication for Dental Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Medication for Dental Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Medication for Dental Sales Value Share by Application (2021-2026) Table 29. Global Medication for Dental Sales Value Share by Application (2027-2032) Table 30. Global Medication for Dental Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medication for Dental Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Medication for Dental Sales Value Share by Region (2021-2026) Table 33. Global Medication for Dental Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Medication for Dental Sales Value Share by Region (2027-2032) Table 35. Global Medication for Dental Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Medication for Dental Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Medication for Dental Sales Value Market Share by Country (2021-2026) Table 38. Global Medication for Dental Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Medication for Dental Sales Value Market Share by Country (2027-2032) Table 40. Teva Company Information Table 41. Teva Business Overview Table 42. Teva Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Teva Medication for Dental Product Portfolio Table 44. Teva Recent Development Table 45. Sun Pharmaceutical Company Information Table 46. Sun Pharmaceutical Business Overview Table 47. Sun Pharmaceutical Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Sun Pharmaceutical Medication for Dental Product Portfolio Table 49. Sun Pharmaceutical Recent Development Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Johnson & Johnson Medication for Dental Product Portfolio Table 54. Johnson & Johnson Recent Development Table 55. Qilu Pharmaceutical Company Information Table 56. Qilu Pharmaceutical Business Overview Table 57. Qilu Pharmaceutical Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Qilu Pharmaceutical Medication for Dental Product Portfolio Table 59. Qilu Pharmaceutical Recent Development Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Novartis Medication for Dental Product Portfolio Table 64. Novartis Recent Development Table 65. Mylan Company Information Table 66. Mylan Business Overview Table 67. Mylan Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Mylan Medication for Dental Product Portfolio Table 69. Mylan Recent Development Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GSK Medication for Dental Product Portfolio Table 74. GSK Recent Development Table 75. Bayer Company Information Table 76. Bayer Business Overview Table 77. Bayer Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bayer Medication for Dental Product Portfolio Table 79. Bayer Recent Development Table 80. Lupin Company Information Table 81. Lupin Business Overview Table 82. Lupin Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Lupin Medication for Dental Product Portfolio Table 84. Lupin Recent Development Table 85. Lingrui Company Information Table 86. Lingrui Business Overview Table 87. Lingrui Medication for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lingrui Medication for Dental Product Portfolio Table 89. Lingrui Recent Development Table 90. Galderma Company Information Table 91. Galderma Business Overview Table 92. Galderma Medication for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Galderma Medication for Dental Product Portfolio Table 94. Galderma Recent Development Table 95. Dr. Reddy's Company Information Table 96. Dr. Reddy's Business Overview Table 97. Dr. Reddy's Medication for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Dr. Reddy's Medication for Dental Product Portfolio Table 99. Dr. Reddy's Recent Development Table 100. CR SANJIU Company Information Table 101. CR SANJIU Business Overview Table 102. CR SANJIU Medication for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. CR SANJIU Medication for Dental Product Portfolio Table 104. CR SANJIU Recent Development Table 105. Cipla Company Information Table 106. Cipla Business Overview Table 107. Cipla Medication for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Cipla Medication for Dental Product Portfolio Table 109. Cipla Recent Development Table 110. Bausch Health Company Information Table 111. Bausch Health Business Overview Table 112. Bausch Health Medication for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Bausch Health Medication for Dental Product Portfolio Table 114. Bausch Health Recent Development Table 115. Aurobindo Company Information Table 116. Aurobindo Business Overview Table 117. Aurobindo Medication for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Aurobindo Medication for Dental Product Portfolio Table 119. Aurobindo Recent Development Table 120. Almirall Company Information Table 121. Almirall Business Overview Table 122. Almirall Medication for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Almirall Medication for Dental Product Portfolio Table 124. Almirall Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Medication for Dental Product Image Figure 2. Global Medication for Dental Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medication for Dental Market Size (2021-2032) & (US$ Million) Figure 4. Global Medication for Dental Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. NSAID Image Figure 8. OTC Analgesic Medications Image Figure 9. Opioid Image Figure 10. Global Medication for Dental Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Medication for Dental Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Medication for Dental Sales Value Share by Type (2021-2032) Figure 13. Drug Store Image Figure 14. Hospital Image Figure 15. Other Image Figure 16. Global Medication for Dental Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medication for Dental Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medication for Dental Sales Value Share by Application (2021-2032) Figure 19. Global Medication for Dental Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Medication for Dental Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Medication for Dental Sales Value (2021-2032) & (US$ Million) Figure 22. North America Medication for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Medication for Dental Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Medication for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Medication for Dental Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Medication for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Medication for Dental Sales Value (2021-2032) & (US$ Million) Figure 28. South America Medication for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Medication for Dental Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Medication for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Medication for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Medication for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Medication for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • NSAID
  • OTC Analgesic Medications
  • Opioid
Applications
  • Drug Store
  • Hospital
  • Other
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Qilu Pharmaceutical
  • Novartis
  • Mylan
  • GSK
  • Bayer
  • Lupin
  • Lingrui
  • Galderma
  • Dr. Reddy's
  • CR SANJIU
  • Cipla
  • Bausch Health
  • Aurobindo
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medication for Dental Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medication for Dental Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medication for Dental Market Dynamics
  1. 2.1 Medication for Dental Industry Trends
  2. 2.2 Medication for Dental Industry Drivers
  3. 2.3 Medication for Dental Industry Opportunities and Challenges
  4. 2.4 Medication for Dental Industry Restraints
3 Medication for Dental Market by Company
  1. 3.1 Global Medication for Dental Company Revenue Ranking in 2025
  2. 3.2 Global Medication for Dental Revenue by Company (2021-2026)
  3. 3.3 Global Medication for Dental Company Ranking (2024-2026)
  4. 3.4 Global Medication for Dental Company Manufacturing Base and Headquarters
  5. 3.5 Global Medication for Dental Company Product Type and Application
  6. 3.6 Global Medication for Dental Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medication for Dental Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medication for Dental Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medication for Dental Market by Type
  1. 4.1 Medication for Dental Type Introduction
  2. 4.1.1 NSAID
  3. 4.1.2 OTC Analgesic Medications
  4. 4.1.3 Opioid
  5. 4.2 Global Medication for Dental Sales Value by Type
  6. 4.2.1 Global Medication for Dental Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medication for Dental Sales Value by Type (2021-2032)
  8. 4.2.3 Global Medication for Dental Sales Value Share by Type (2021-2032)
5 Medication for Dental Market by Application
  1. 5.1 Medication for Dental Application Introduction
  2. 5.1.1 Drug Store
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Medication for Dental Sales Value by Application
  6. 5.2.1 Global Medication for Dental Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medication for Dental Sales Value by Application (2021-2032)
  8. 5.2.3 Global Medication for Dental Sales Value Share by Application (2021-2032)
6 Medication for Dental Regional Value Analysis
  1. 6.1 Global Medication for Dental Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medication for Dental Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medication for Dental Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medication for Dental Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medication for Dental Sales Value (2021-2032)
  7. 6.3.2 North America Medication for Dental Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medication for Dental Sales Value (2021-2032)
  10. 6.4.2 Europe Medication for Dental Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medication for Dental Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medication for Dental Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medication for Dental Sales Value (2021-2032)
  16. 6.6.2 South America Medication for Dental Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medication for Dental Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medication for Dental Sales Value Share by Country, 2025 VS 2032
7 Medication for Dental Country-level Value Analysis
  1. 7.1 Global Medication for Dental Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medication for Dental Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medication for Dental Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medication for Dental Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medication for Dental Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medication for Dental Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medication for Dental Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medication for Dental Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medication for Dental Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medication for Dental Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medication for Dental Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medication for Dental Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medication for Dental Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medication for Dental Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medication for Dental Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medication for Dental Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medication for Dental Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medication for Dental Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medication for Dental Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medication for Dental Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medication for Dental Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medication for Dental Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medication for Dental Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medication for Dental Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medication for Dental Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medication for Dental Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medication for Dental Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medication for Dental Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medication for Dental Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medication for Dental Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medication for Dental Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medication for Dental Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medication for Dental Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medication for Dental Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medication for Dental Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medication for Dental Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medication for Dental Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medication for Dental Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medication for Dental Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medication for Dental Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medication for Dental Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medication for Dental Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medication for Dental Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medication for Dental Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medication for Dental Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medication for Dental Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medication for Dental Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medication for Dental Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medication for Dental Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medication for Dental Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medication for Dental Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medication for Dental Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medication for Dental Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medication for Dental Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medication for Dental Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medication for Dental Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medication for Dental Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medication for Dental Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medication for Dental Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medication for Dental Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medication for Dental Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medication for Dental Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medication for Dental Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medication for Dental Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medication for Dental Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medication for Dental Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medication for Dental Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medication for Dental Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medication for Dental Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medication for Dental Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medication for Dental Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medication for Dental Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medication for Dental Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medication for Dental Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medication for Dental Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medication for Dental Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medication for Dental Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medication for Dental Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medication for Dental Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medication for Dental Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medication for Dental Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medication for Dental Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medication for Dental Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medication for Dental Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medication for Dental Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medication for Dental Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medication for Dental Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medication for Dental Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Medication for Dental Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Medication for Dental Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Medication for Dental Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Medication for Dental Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Medication for Dental Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Medication for Dental Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Qilu Pharmaceutical
  20. 8.4.1 Qilu Pharmaceutical Company Information
  21. 8.4.2 Qilu Pharmaceutical Business Overview
  22. 8.4.3 Qilu Pharmaceutical Medication for Dental Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Qilu Pharmaceutical Medication for Dental Product Portfolio
  24. 8.4.5 Qilu Pharmaceutical Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Medication for Dental Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Medication for Dental Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Medication for Dental Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Medication for Dental Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Medication for Dental Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSK Medication for Dental Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Medication for Dental Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Medication for Dental Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Lupin
  50. 8.9.1 Lupin Company Information
  51. 8.9.2 Lupin Business Overview
  52. 8.9.3 Lupin Medication for Dental Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lupin Medication for Dental Product Portfolio
  54. 8.9.5 Lupin Recent Developments
  55. 8.10 Lingrui
  56. 8.10.1 Lingrui Company Information
  57. 8.10.2 Lingrui Business Overview
  58. 8.10.3 Lingrui Medication for Dental Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lingrui Medication for Dental Product Portfolio
  60. 8.10.5 Lingrui Recent Developments
  61. 8.11 Galderma
  62. 8.11.1 Galderma Company Information
  63. 8.11.2 Galderma Business Overview
  64. 8.11.3 Galderma Medication for Dental Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Galderma Medication for Dental Product Portfolio
  66. 8.11.5 Galderma Recent Developments
  67. 8.12 Dr. Reddy's
  68. 8.12.1 Dr. Reddy's Company Information
  69. 8.12.2 Dr. Reddy's Business Overview
  70. 8.12.3 Dr. Reddy's Medication for Dental Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Reddy's Medication for Dental Product Portfolio
  72. 8.12.5 Dr. Reddy's Recent Developments
  73. 8.13 CR SANJIU
  74. 8.13.1 CR SANJIU Company Information
  75. 8.13.2 CR SANJIU Business Overview
  76. 8.13.3 CR SANJIU Medication for Dental Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CR SANJIU Medication for Dental Product Portfolio
  78. 8.13.5 CR SANJIU Recent Developments
  79. 8.14 Cipla
  80. 8.14.1 Cipla Company Information
  81. 8.14.2 Cipla Business Overview
  82. 8.14.3 Cipla Medication for Dental Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cipla Medication for Dental Product Portfolio
  84. 8.14.5 Cipla Recent Developments
  85. 8.15 Bausch Health
  86. 8.15.1 Bausch Health Company Information
  87. 8.15.2 Bausch Health Business Overview
  88. 8.15.3 Bausch Health Medication for Dental Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bausch Health Medication for Dental Product Portfolio
  90. 8.15.5 Bausch Health Recent Developments
  91. 8.16 Aurobindo
  92. 8.16.1 Aurobindo Company Information
  93. 8.16.2 Aurobindo Business Overview
  94. 8.16.3 Aurobindo Medication for Dental Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aurobindo Medication for Dental Product Portfolio
  96. 8.16.5 Aurobindo Recent Developments
  97. 8.17 Almirall
  98. 8.17.1 Almirall Company Information
  99. 8.17.2 Almirall Business Overview
  100. 8.17.3 Almirall Medication for Dental Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Almirall Medication for Dental Product Portfolio
  102. 8.17.5 Almirall Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst